trial

Joint Crisis Plan Effectiveness in Preventing Relapses in Schizophrenia and Schizoaffective Disorder

NCTId NCT02627716
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 124 (actual)
Sponsored by University Hospital, Lille
Primary completion 2016-03-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
124 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2014-12-05
Primary completion
2016-03-10
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
SOS Plan

Sponsors

University Hospital, LilleLead Sponsor
Ministry of Health, FranceCollaborator

Investigators

1
Guillaume VAIVAPrincipal Investigator

Sites

4 total
Brest, FranceCaen, FranceLille, FranceParis, France

Facts & assertions

4 sourced
Enrollment
124
Phase
NA
Primary Completion Date
2016-03-10
Status
COMPLETED
relationships
The graph out of here
drug
SOS Plan
drug
lead_sponsor
University Hospital, Lille
company
collaborator
Ministry of Health, France
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Guillaume VAIVA
person